Putting Patients First Blog
JANUARY 10, 2024
Making available more specific information about total costs and coverage will ensure that all consumers have comprehensive information to help them make smart health care decisions. These resources should aim to clarify insurance terms and concepts, aiding consumers in navigating the complexities of selecting a health plan.
Putting Patients First Blog
MARCH 4, 2024
Under the new Manufacturer Discount Program, manufacturers will be required to provide discounts on applicable drugs during the initial coverage phase and catastrophic phase of the defined standard Part D drug benefit.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
NOVEMBER 30, 2022
The company’s weight loss drug Saxenda (liraglutide) won an approval for chronic weight management in December 2014, and Wegovy (semaglude) got the same tag in 2021. In the US, most private health insurers have been slow to cover the cost of anti-obesity therapeutics. Novo Nordisk is another company leading the charge in this field.
Pharmaceutical Technology
NOVEMBER 30, 2022
The company’s weight loss drug Saxenda (liraglutide) won an approval for chronic weight management in December 2014, and Wegovy (semaglude) got the same tag in 2021. In the US, most private health insurers have been slow to cover the cost of anti-obesity therapeutics. Novo Nordisk is another company leading the charge in this field.
Pharmaceutical Technology
MAY 26, 2023
Mackey says that people may seek medications due to issues with health insurance policies, variable coverage for certain conditions, lack of access, and more. In 2014, the US National Association of Boards of Pharmacy (NABP) launched the “.pharmacy” The FDA also caught the latter website selling unapproved and misbranded drugs.
Expert insights. Personalized for you.
40 
Let's personalize your content